gadoversetamide (OptiMARK)

nonionic, linear chelate used for magnetic resonance imaging of brain and spine
Also Known As:
OptiMARK; Mallinckrodt brand of gadoversetamide; Tyco brand of gadoversetamide
Networked: 18 relevant articles (0 outcomes, 3 trials/studies)

Drug Context: Research Results


1. Grothues, F: 2 articles (12/2008 - 01/2007)
2. Wible, James H: 2 articles (02/2008 - 12/2007)
3. Napoli, Alicia: 2 articles (02/2008 - 11/2006)
4. Banderali, Giuseppe: 1 article (08/2014)
5. David, Vincenzo: 1 article (08/2014)
6. Guastalla, Pierpaolo: 1 article (08/2014)
7. Stacul, Fulvio: 1 article (08/2014)
8. Quaranta, Roberto: 1 article (08/2014)
9. Zuppa, Antonio Alberto: 1 article (08/2014)
10. Cova, Maria Assunta: 1 article (08/2014)

Related Diseases

1. Myocardial Infarction
2. Body Weight (Weight, Body)
3. Nephrogenic Fibrosing Dermopathy
01/01/2009 - "Nephrogenic systemic fibrosis associated with gadoversetamide exposure: treatment with sodium thiosulfate."
12/01/2009 - "In patients with impaired renal function and nephrogenic systemic fibrosis (NSF), the agents gadodiamide, gadoversetamide, and gadopentetate dimeglumine have been shown to result in Gd deposition in the skin and internal organs. "
08/01/2014 - "Breastfeeding is safe for the nursing infant of any post-conceptional age after administration of the majority of radiological contrast media to the mother; only gadolinium-based agents considered at high risk of nephrogenic systemic fibrosis (gadopentetate dimeglumine, gadodiamide, gadoversetamide) should be avoided in the breastfeeding woman as a precaution; there is no need to temporarily discontinue breastfeeding or to express and discard breast milk following the administration of contrast media assessed as compatible with breastfeeding. "
10/01/2012 - "Nephrogenic systemic fibrosis (NSF) has been reported in humans to be most likely induced by gadolinium based contrast agents (GBCA), namely by gadodiamide, gadopentetate dimeglumine, and gadoversetamide, rarely by other GBCA. "
09/01/2007 - "Information was obtained from PubMed, International Pharmaceutical Abstracts, Iowa Drug Information Service, and Google Scholar, using the unlimited search terms nephrogenic systemic fibrosis, NSF, nephrogenic fibrosing dermopathy, NFD, gadolinium, gadodiamide, gadoversetamide, gadopentetate, gadobenate, and gadoteridol. "
4. Hypocalcemia
5. Renal Insufficiency (Renal Failure)

Related Drugs and Biologics

1. gadoversetamide (OptiMARK)
2. Gadolinium DTPA (Magnevist)
3. gadodiamide (Omniscan)
4. Gadolinium
5. Contrast Media
6. gadoteridol (Prohance)
7. Calcium
8. gadoterate meglumine
9. gadobenic acid (gadobenate dimeglumine)
10. N-formyl-13-dihydrocarminomycin (NFD)

Related Therapies and Procedures

1. Intravenous Injections